Most recently, Candid Therapeutics raised $370.0M in its Early Stage VC (Series B) (Aug 2024).
- ·The complete investor list: 21 names
- ·Watch Candid Therapeutics: the Monday email on marks, rounds and moves
Candid Therapeutics round by round
1 roundsHow much has Candid Therapeutics raised?
Candid Therapeutics has raised $445 million across 1 recorded round since 2024. The largest was a $370 million Series B in Aug 2024.
Candid Therapeutics has filed 1 Form D with the SEC, most recently in Sep 2024 ($206 million sold to 33 investors).
Candid Therapeutics investors
21 investors are on record for Candid Therapeutics, including Fidelity Management & Research Company, Qiming Venture Partners, OrbiMed and Franklin Resources. By type, the record holds 6 venture capital firms, 2 private equity firms and 1 asset manager. The Series B in Aug 2024 drew 20 investors.
21 investors have backed Candid Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Candid Therapeutics
- How much has Candid Therapeutics raised?
- Candid Therapeutics has raised $445.0M in total across 1 recorded funding rounds.
- When was Candid Therapeutics's last funding round?
- Candid Therapeutics's most recent recorded round was Early Stage VC (Series B) in Aug 2024, raising $370.0M.